Bassil et al. evaluated exendin-4 treatment in transgenic MSA mice and observed increased insulin receptor density in the most severely affected brain regions, reduced monomeric α-synuclein load in the striatum and protective effect on survival of nigral dopamine neurons [144]. This evidence concerns the gene SNCA and multiple system atrophy.